Elevated rates of substance use (alcohol, tobacco, cannabis) have been reported in people at clinical high risk (CHR) of developing psychosis and there is some evidence that substance use may be higher in those who convert to a psychosis compared to non-converters. However little is known about the predictive value of substance use on risk of conversion to psychosis in those at CHR of psychosis. In the current study, 170 people at CHR of psychosis were assessed at baseline on severity of alcohol, tobacco and cannabis using the Alcohol and Drug Use Scale. Participants were recruited across three sites over a four year period as part of the Enhancing the Prospective Prediction of Psychosis (PREDICT) study. Predictors of conversion to psychosis were examined using Cox proportional hazards models. Results revealed that low use of alcohol, but neither cannabis use nor tobacco use at baseline, contributed to the prediction of psychosis in the CHR sample. Prediction algorithms incorporating combinations of additional baseline variables known to be associated with psychotic conversion may result in increased predictive power compared with substance use alone.
Introduction
In a recent review, Addington et al. (2014) identified ten studies that examined substance use in people who are at clinical high risk (CHR) of developing psychosis. Across these studies, the most commonly used substances were cannabis, alcohol and tobacco, with cannabis and tobacco use being higher than in healthy controls (Auther et al., 2012) , and with rates similar to those experiencing a first-episode of psychosis (Sevy et al., 2001; Barnett et al., 2007; Cooper et al., 2012) . Fewer studies have examined the relationship between substance use and conversion to psychosis in CHR. Cannon et al. (2008) reported that a history of any substance abuse was one of five predictors of conversion to psychosis in a multivariate model. Kristensen and Cadenhead (2007) found that CHR individuals were more likely to develop psychosis within one year if they had used tobacco or met criteria for cannabis abuse/dependence. Several of the remaining studies examining substance use in those at CHR have reported no significant relationships between severity of use and later conversion to psychosis (Phillips et al., 2002; Ruhrmann et al., 2010; Thompson et al., 2011; Auther et al., 2012) . However, some studies evaluated cannabis only (Korver et al., 2010) , or recorded the use of any substance globally rather than multiple individual ones (Cannon et al., 2008; Thompson et al., 2011) . In addition, it may be important to consider the role of positive symptoms as there is some evidence that cannabis use may be related to positive symptom severity (Corcoran et al., 2008; Korver et al., 2010) . Furthermore, the negative studies may be underpowered to demonstrate a positive relation between substance use and conversion, or employed statistical tests insensitive to the predictive value of substance use for psychosis onset. As such, it is unclear whether there is an effect of substance use on conversion to psychosis in CHR individuals.
Therefore, the aim of the current prospective study was to examine in a large, well characterized sample of individuals at CHR of psychosis: 1) severity of substance use at baseline in people who converted to a psychosis compared to non-converters over a four year period, and 2) the relationship between substance use at baseline and rate of conversion to psychosis.
Materials and methods

Sample
One-hundred and seventy (96 males, 74 females) individuals at CHR of psychosis participated as part of a multi-site NIMH funded study "Enhancing the Prospective Prediction of Psychosis" (PREDICT). This was a 
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Schizophrenia Research j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / s c h r e s 4-year longitudinal observational study to determine predictors of conversion to psychosis in individuals at CHR of developing psychosis who were not using anti-psychotic medication. The study was conducted at the Universities of Toronto, North Carolina, and Yale. All CHR individuals met the Criteria of Prodromal States (COPS) based on the Structured Interview for Prodromal Syndromes (SIPS) (McGlashan et al., 2010) . One hundred sixty-seven CHR participants met attenuated positive symptom syndrome (APSS) criteria, which includes the emergence or worsening of a non-psychotic level disturbance in thought content, thought process or perceptual abnormality over the past year, six participants met criteria for genetic risk and deterioration (GRD), which required either a first degree relative with a psychotic disorder or the subject having schizotypal personality disorder plus at least a 30% drop in functioning on the General Assessment of Functioning (GAF) scale in the past 12 months, and three participants met both APSS and GRD.
Participants were excluded if they met criteria for any current or lifetime axis I psychotic disorder, prior history of treatment with an antipsychotic, IQ b 70, or past or current history of a clinically significant central nervous system disorder that may confound or contribute to clinical high risk symptoms, or using antipsychotics at baseline. Antipsychotics were not used at any later points in this study.
Measures
Criteria for a prodromal syndrome and for conversion to psychosis were determined using the SIPS (McGlashan et al., 2010) . Conversion meant that at least one of the five attenuated positive symptoms reached a psychotic level of intensity (rated 6) for a frequency of ≥1 h/day for 4 days/week during the past month or that symptoms seriously impacted functioning (e.g. severely disorganized or dangerous to self or others). Symptoms were assessed with the Scale of Prodromal Symptoms (SOPS), which consists of 19 items in 4 symptom domains: positive, negative, general, and disorganized.
Participants were rated on substance use with a well-established rating scale, the Alcohol and Drug Use Scale (AUS/DUS) (Drake et al., 1996) . The AUS/DUS was used to record severity of substance use within the past month. It is a 5-point scale with anchors that are equivalent to 1 = abstinent, 2 = use without impairment, 3 = abuse, 4 = dependence and 5 = severe dependence. Ratings of 3 and 4 reflect behaviors equivalent to DSM-IV diagnoses of abuse and dependence. Severity ratings were recorded for alcohol, tobacco, cannabis, cocaine, opiates, PCP, amphetamine, MDMA, GHB, huffing, hallucinogens and other substances at baseline.
Statistical analysis
Differences in baseline characteristics of converters vs non-converters were evaluated by either t-tests (continuous data), or χ 2 or Fisher's exact tests (categorical data). Pearson's rho was used to correlate substance use with age and symptom severity. Substance use variables were nonnormally distributed and non-transformable; therefore, Mann-Whitney U tests were used to compare substance use severity at baseline between groups. Cox proportional hazard regression models were used to estimate the association of substance use with conversion to psychosis. The assumption of proportionality was violated for ratings of tobacco use; therefore, ratings of 2-4 were combined as any use. The analysis of time to conversion was calculated in days since entry into the study. Follow-up for non-converters was calculated as the last date when SOPS ratings were acquired within 4 years. The effects of risk factors are described by their Cox regression hazard ratio (HR) and 95% confidence intervals. We first considered a model which included all the predictors that had a p-value of b0.25 in the univariate analyses, with an aim to drop the least significant variable, then continue by successively refitting the model and applying the same backward elimination rule until all remaining variables were statistically significant. Statistical analyses were conducted using SPSS 20.0 and SAS 9.2.
Procedures
All three sites involved in this longitudinal study of predictors of conversion to psychosis recruited CHR individuals. Raters were experienced research clinicians who demonstrated adequate reliability at routine reliability checks. Gold standard post-training agreement on the critical threshold for determining initial eligibility and subsequent conversion status based on the SIPS was excellent (kappa = .90). The PI or clinical psychiatrist or psychologist at each site conducted a comprehensive clinical assessment to determine if entry criteria were met. JA chaired weekly conference calls to review criteria for all individuals admitted to the study. The study protocols and informed consents Master's degree completed 2 2.1 1 3.4
